233 related articles for article (PubMed ID: 1360505)
21. Binding of pyrimethamine to human plasma proteins and erythrocytes.
Rudy AC; Poynor WJ
Pharm Res; 1990 Oct; 7(10):1055-60. PubMed ID: 2281036
[TBL] [Abstract][Full Text] [Related]
22. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
[TBL] [Abstract][Full Text] [Related]
23. Serum protein binding of tolterodine and its major metabolites in humans and several animal species.
Påhlman I; Gozzi P
Biopharm Drug Dispos; 1999 Mar; 20(2):91-9. PubMed ID: 10206324
[TBL] [Abstract][Full Text] [Related]
24. Binding of lopinavir to human alpha1-acid glycoprotein and serum albumin.
Gulati A; Boudinot FD; Gerk PM
Drug Metab Dispos; 2009 Aug; 37(8):1572-5. PubMed ID: 19439488
[TBL] [Abstract][Full Text] [Related]
25. Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein.
Eap CB; Cuendet C; Baumann P
Clin Pharmacol Ther; 1990 Mar; 47(3):338-46. PubMed ID: 2311335
[TBL] [Abstract][Full Text] [Related]
26. Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentration.
Baruzzi A; Contin M; Perucca E; Albani F; Riva R
Eur J Clin Pharmacol; 1986; 31(1):85-9. PubMed ID: 3780833
[TBL] [Abstract][Full Text] [Related]
27. Disposition of oral quinine in acute falciparum malaria.
Supanaranond W; Davis TM; Pukrittayakamee S; Silamut K; Karbwang J; Molunto P; Chanond L; White NJ
Eur J Clin Pharmacol; 1991; 40(1):49-52. PubMed ID: 2060545
[TBL] [Abstract][Full Text] [Related]
28. Binding of quinine to plasma proteins in falciparum malaria.
Silamut K; White NJ; Looareesuwan S; Warrell DA
Am J Trop Med Hyg; 1985 Jul; 34(4):681-6. PubMed ID: 3896000
[TBL] [Abstract][Full Text] [Related]
29. Protein binding of nifedipine.
Otto J; Lesko LJ
J Pharm Pharmacol; 1986 May; 38(5):399-400. PubMed ID: 2872322
[TBL] [Abstract][Full Text] [Related]
30. Use of 1-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albumin.
Essassi D; Zini R; Tillement JP
J Pharm Sci; 1990 Jan; 79(1):9-13. PubMed ID: 2313585
[TBL] [Abstract][Full Text] [Related]
31. Protein binding predictions in infants.
McNamara PJ; Alcorn J
AAPS PharmSci; 2002; 4(1):E4. PubMed ID: 12049488
[TBL] [Abstract][Full Text] [Related]
32. Nomogram for estimating plasma unbound disopyramide concentrations in patients with varying plasma alpha 1-acid glycoprotein concentrations.
Echizen H; Ishikawa S; Koike K; Ishizaki T
Ther Drug Monit; 1995 Apr; 17(2):145-52. PubMed ID: 7624903
[TBL] [Abstract][Full Text] [Related]
33. Quinine pharmacokinetics in chronic haemodialysis patients.
Roy L; Bannon P; Villeneuve JP;
Br J Clin Pharmacol; 2002 Dec; 54(6):604-9. PubMed ID: 12492607
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors: the role of alpha-1-acid glycoprotein binding.
Graham RA; Lum BL; Cheeti S; Jin JY; Jorga K; Von Hoff DD; Rudin CM; Reddy JC; Low JA; Lorusso PM
Clin Cancer Res; 2011 Apr; 17(8):2512-20. PubMed ID: 21300760
[TBL] [Abstract][Full Text] [Related]
35. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.
David BM; Ilett KF; Whitford EG; Stenhouse NS
Br J Clin Pharmacol; 1983 Apr; 15(4):435-41. PubMed ID: 6849779
[TBL] [Abstract][Full Text] [Related]
36. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
Morse DS; Abernethy DR; Greenblatt DJ
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
[TBL] [Abstract][Full Text] [Related]
37. The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein.
Veering BT; Burm AG; Souverijn JH; Serree JM; Spierdijk J
Br J Clin Pharmacol; 1990 Feb; 29(2):201-6. PubMed ID: 2306411
[TBL] [Abstract][Full Text] [Related]
38. Changes in the serum protein binding of vancomycin in patients with methicillin-resistant Staphylococcus aureus infection: the role of serum alpha 1-acid glycoprotein levels.
Morita K; Yamaji A
Ther Drug Monit; 1995 Apr; 17(2):107-12. PubMed ID: 7624896
[TBL] [Abstract][Full Text] [Related]
39. Binding of catecholamines to alpha-1 acid glycoprotein, albumin and lipoproteins in human serum.
Sager G; Bratlid H; Little C
Biochem Pharmacol; 1987 Nov; 36(21):3607-12. PubMed ID: 3675618
[TBL] [Abstract][Full Text] [Related]
40. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
